Hernández GA, Sánchez MJ, Sobrino CS, Alonso LO, Delgado CL, Frías MM

Language: Spanish
References: 18
Page: 22-30
PDF size: 78.20 Kb.

ABSTRACT

Objective: To determine the factors prognostics of early mortality in the malignant billary estenosis after the endoscopic derivation. Background data: The surgical, percutaneous or endoscopic derivation is the alternative of palliative treatment in the biliary obstruction unresectable. The factors prognostic the early mortality after surgical derivation are: hemoglobin ‹ 10 g/dL, serum bilirubin › 10 mg/dL and serum albumin ‹ 2.5 g/dL; for the percutaneous derivation they are the sanguineous urea more of 4.3 mmol/L and hemoglobin ‹ 10.9 g/dL; whereas in the single endoscopic derivation type 3 of Bismuth and the infectious complications after the endoscopic colangiography and the absence of the clinical success were factors prognoses of early mortality. Methods: Descriptive and retrospective analysis of 97 cases with malignant biliary obstruction. The factors were evaluated prognoses of early mortality. Univariated and bivaried analysis and of survival by the method of Kaplan-Meier was made curved. Results: 97 cases were included that presented/displayed unresectable disease and had a biochemical control subsequent to the drainage. They were 58 women and 39 men. More frequent symptoms: ictericia, pain and prurito. 61 cases of distal obstruction and 36 with proximal obstruction. Twenty deaths (25.9%) happened within the 30 later days to the treatment. The bilirubin ›14 mg/dL and the proximal location were like predicting of early mortality. Conclusions: The obstruction biliary more frequent is located in choledocho distal and is of pancreatic origin. The main factors associated to early mortality are: the bilirubin › of 14 mg/dL and the proximal location reason why is important the suitable selection of patient candidates to endoscopic derivation. The survival is better in the distal obstruction.

REFERENCES

1. Carole RF, Mark HD, Aronson N. Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies. Gastrointest Endoscopy 2002; 56(6): 218-25.

2. Hawes RH. ERCP. In: Pancreaticobiliary malignancy. Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies. Gastrointest Endoscopy 2002; 56(6): s201-s206.

3. Shirahatti RG, Alphonso N, Joshi RM, Prasad KV, Wagle PK. Palliative surgery in malignant obstructive: prognostic indicators of early mortality. JR Coll Surg Edinb 1997; 42(4): 238-43.

4. Rai R, Dick R, Doctor N, Dafnios N, Morris R, Davidson BR. Predicting early mortality following percutaneous stent insertion for malignant biliary obstruction: a multivariate risk factor analysis. Eur J Gastroenterol Hepatol 2000; 12(10): 1095-100.

5. Ducreux M, Liguory C, Lefebvre JF, Ink O, Choury A, Fritsch J, Bonnel D, Derhy S, Etienne JP. Management of malignant biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 1992; 37(5): 778-83.

6. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WMC, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51 (Suppl. VI): vi 1- vi9.

7. Beilstein MC, Kochman ML. Biliary endoscopy. Curr Opin Gastroenterol 2003; 19: 281-7.

8. Ochoa CFJ. Colangiocarcinoma. Rev Gastroenterol Mex 1997; 62(3): 194-200.

9. Martínez-González N, Mondragón-Sánchez R, Gómez-Gómez R y cols. Factores epidemiológicos y resultados de tratamiento del colangiocarcinoma periférico y perihiliar. Rev Gastroenterol Mex 2002; 67(4): 250-8.

10. Ueno H, Okada S, Okisaka T, Ikeda M. Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 2000; 59(4): 296-301.

11. Lacaine F, Fourtanier G, Fingerthut A, Hay JM. Surgical mortality and morbidity in malignant obstructive jaundice: a prospective multivariate analysis. Eur J Surg 1995; 161(10): 729-34.

12. Ikeda M, Okada S, Yamamoto S, Sato T, Ueno H, Okisaka T, Kuriyama H, Takayasu K, Furukawa H, Iwata R. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol 2002; 32(11): 455-60.

13. Kiriyama H, Okada S, Okisaka T, Ueno H, Ikeda M. Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection. Gastroenterol Hepatol 2002; 17(11): 1205-10.

14. Malagoni MA, McCoy DM, Richardson JD, Flint LM. Effective palliation of malignant biliary duct obstruction. Ann Surg 1985; 201(5): 554-9.

15. Ettinghausen SE, Schwartzenruber DJ, Sindelar WF. Evolving strategies for the treatment of adenocarcinoma of the pancreas. J Clin Gastroenterol 1995; 21: 48-60.

16. Pereira-Lima JC, Jakobs R, Maier M, Benz C, Kohler B, Riemann JF. Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival, predictive factors, and comparison of 10-French with 11.5-French gauge stents. Am J Gastroenterol 1996; 91(10): 2179-84.

17. Engelken FJ, Bettschart V, Rahman MQ, Parks RW, Garden OJ. Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol 2003; 29(4): 368-73.

18. Deviere J, Baize M, De Toeve J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988; 34: 95-101.